Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo

Oncogene

Volumn 22, Issue 44, 2003, Pages 6865-6872

  Shah, Khalid ^a   Tang, Yi ^a   Breakefield, Xandra ^a   Weissleder, Ralph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Apoptosis; Bioluminescence; TRAIL

Indexed keywords

LUCIFERASE; LUCIFERIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

AMPLICON; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOLUMINESCENCE; CANCER GRAFT; CANCER INHIBITION; CONTROLLED STUDY; GLIOMA; HERPES SIMPLEX VIRUS; HUMAN; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL SURVIVAL; CELL TRANSPLANTATION; COMPUTER SYSTEMS; GENES, REPORTER; GENETIC VECTORS; GLIOMA; GREEN FLUORESCENT PROTEINS; HERPESVIRUS 1, HUMAN; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUCIFERASES; LUMINESCENT MEASUREMENTS; LUMINESCENT PROTEINS; MEMBRANE GLYCOPROTEINS; MICE; MICE, NUDE; RECOMBINANT FUSION PROTEINS; TIME FACTORS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; HUMAN HERPESVIRUS 1; RENILLA; SIMPLEXVIRUS;

EID: 0242490131     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206748     Document Type: Article

References (41)

1. Ashkenazi A and Dixit VM. (1998). Science, 281, 1305-1308.
2. Ashkenazi A and Dixit VM. (1999). Curr. Opin. Cell Biol., 11, 255-260 (Review).
3. Bhumik S and Gambhir SS. (2002). Proc. Natl. Acad. Sci. USA, 99, 377-382.
4. Boviatsis EJ, Scharf JM, Chase M, Harrington K, Kowall NW, Breakefield XO and Chiocca EA. (1994). Gene Ther., 1, 323-331.
5. Chinnaiyan AM, Prasad U, Shankar S, Hamstra DA, Shanaiah M, Chenevert TL, Ross BD and Rehemtulla A. (2000). Proc. Natl. Acad. Sci. USA, 97, 1754-1759.
6. Contag PR, Olomu IN, Stevenson DK and Contag CH. (1998). Nat. Med., 4, 245-247.
7. Contag CH and Buchmann MH. (2002). Ann. Rev. Biomed. Eng., 4, 235-260.
8. Contag CH, Jenkins D, Contag PR and Negrin RS. (2000). Neoplasia, 2, 41-52 (Review).
9. Di X, Nishizaki T, Harada K, Kajiwara K, Nakayama H and Ito H. (1997). J. Exp. Clin. Cancer Res., 16, 389-394.
10. Evan S and Littlewood V. (1998). Science, 281, 1317-1322 (Review).
11. Evan GL, Brown L, Whyte M and Harrington E. (1995). Curr. Opin. Cell Biol., 7, 825-834 (Review).
12. Fraefel C, Jacoby DR and Breakefield XO. (2000). Adv. Virus Res., 55, 425-452.
13. Fulci G and Chiocca EA. (2003). Front Bioscience, 8, 346-360 (Review).
14. Gambhir S. (2002). Nat. Rev. Cancer, 2, 683-693 (Review).
15. Gliniak B and Le T. (1999). Cancer Res., 59, 6153-6158.
16. Griffith TS and Broghammer FL. (2001). Mol. Ther., 4, 257-266.
17. Griffith TS, Anderson RD, Davidson BL, Williams RD and Ratliff TL. (2000). J. Immunol., 165, 2886-2894.
18. Gruss HJ and Dower SK. (1995). Blood, 85, 3378-3404 (Review).
19. Jo M, Kim TH, Seol DW, Esplen JE, Dorko K, Billiar TR and Strom SC. (2000). Nat. Med., 6, 564-567.
20. Kagawa S, He C, Gu J, Koch P, Rha SJ, Roth JA, Curley SA, Stephens LC and Fang B. (2001). Cancer Res., 61, 3330-3338.
21. Kashima T, Vinters HV and Campagnoni AT. (1995). J. Neuropathol. Exp. Neurol., 54, 23-31.
22. Lawrence D, Shahrokh Z, Marsters S, Achilles K, Shih D, Mounho B, Hillan K, Totpal K, DeForge L, Schow P, Hooley J, Sherwood S, Pai R, Leung S, Khan L, Gliniak B, Bussiere J, Smith CA, Strom SS, Kelley S, Fox JA, Thomas D and Ashkenazi A. (2001). Nat. Med., 7, 383-385.
23. LeBlanc HN and Ashkenazi A. (2003). Cell Death Differ., 10, 66-75.
24. Luker GD, Bardill JP, Prior JL, Pica CM, Piwnica-Worms D and Leib DA. (2002). J. Virol., 76, 12149-12161.
25. Marsters SA, Pitti RM, Donahue CJ, Ruppert S, Bauer KD and Ashkenazi A. (1996). Curr. Biol., 6, 750-752.
26. Morgenstern JP and Land H. (1990). Nucleic Acids Res., 18, 3587-3596.
27. Nagata S. (1997). Cell, 88, 355-365.
28. Nitsch R, Bechmann I, Deisz RA, Haas D, Lehmann TN, Wendling U and Zipp F. (2000). Lancet, 356, 827-828.
29. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A and Ashkenazi A. (1996). J. Biol. Chem., 271, 12687-12690.
30. Pulkkanen KJ, Parkkinen JJ, Laukkanen JM, Kettunen MI, Tyynela K, Kauppinen RA, Ala-Opas MY and Yla-Herttuala S. (2001). Cancer Gene Ther., 8, 529-536.
31. Rehemtulla A, Stegman LD, Cardozo SJ, Gupta S, Hall DE, Contag CH and Ross BD. (2000). Neoplasia, 2, 491-495.
32. Rieger J, Naumann U, Glaser T, Ashkenazi A and Weller M. (1998). FEBS Lett., 427, 124-129.
33. Saeki Y, Fraefel C, Ichikawa T, Breakefield XO and Chiocca EA. (2001). Mol. Ther., 3, 591-601.
34. Shen Y and Shenk TE. (1995). Curr. Opin. Genet. Dev., 5, 105-111 (Review).
35. Tjuvajev JG, Doubrovin M, Akhurst T, Cai S, Balatoni J, Alauddin MM, Finn R, Bornmann W, Thaler H, Conti PS and Blasberg RG. (2002). J. Nucl. Med., 43, 1072-1083.
36. Vaux DL. (1993). Proc. Natl. Acad. Sci. USA, 90, 786-789 (Review).
37. Voelkel-Johnson C, King DL and Norris JS. (2002). Cancer Gene Ther., 9, 164-172.
38. Wajant H, Pfizenmaier K and Scheurich P. (2002). Apoptosis, 7, 449-459.
39. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC and Lynch DH. (1999a). Nat. Med., 5, 157-163.
40. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC and Lynch DH. (1999b). Nat. Med., 5, 157-163.
41. Weissleder R. (2002). Nat. Rev. Cancer, 2, 11-18 (Review).